<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>sustained tumor elimination &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/sustained-tumor-elimination/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 12:46:36 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>sustained tumor elimination &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Revolutionary ‘Smart’ Immune Cells: A Game-Changer in Sustained Tumor Elimination</title>
		<link>https://bioengineer.org/revolutionary-smart-immune-cells-a-game-changer-in-sustained-tumor-elimination/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 02 Apr 2025 21:18:38 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[EchoBack CAR T-cells]]></category>
		<category><![CDATA[engineered T-cells for tumor targeting]]></category>
		<category><![CDATA[smart immune cells]]></category>
		<category><![CDATA[sustained tumor elimination]]></category>
		<category><![CDATA[ultrasound-activated cancer therapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/revolutionary-smart-immune-cells-a-game-changer-in-sustained-tumor-elimination/</guid>

					<description><![CDATA[Imagine a future where battles against stubborn solid tumors are fought not with traditional therapies that often come with devastating side effects, but with engineered immune cells designed for precision targeting. Researchers at the University of Southern California (USC) have unveiled a pioneering advancement in cancer treatment: the EchoBack CAR T-cell. These cells are part [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">239908</post-id>	</item>
	</channel>
</rss>
